Clinical Trial Update: Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia [Phase 2]

View source ↗

Summary

Phase 2 extension trial results for ABP-450 evaluating safety and efficacy of repeat treatments in cervical dystonia; the extension study has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• ABP-450

Snippet

Sponsor: AEON Biopharma, Inc. | Conditions: Cervical Dystonia | Phase 2 | Status: COMPLETED | Results posted: 2024-08-22